Stock Events

Dai Han Pharmaceutical 

₩25,300
2
-₩200-0.78% Today

Statistics

Day High
25,500
Day Low
25,250
52W High
29,650
52W Low
25,200
Volume
1,526
Avg. Volume
8,770
Mkt Cap
151.7B
P/E Ratio
-
Dividend Yield
2.94%
Dividend
744.12

Upcoming

27
DEC
Dividend Ex
Estimated
 
19
APR 25
Dividend Payment
Estimated
 
27
DEC 25
Dividend Ex
Estimated
 
19
APR 26
Dividend Payment
Estimated
 

Dividends

2.94%Dividend Yield
Apr 24
₩750
Apr 23
₩650
Apr 22
₩400
Apr 21
₩400
Apr 20
₩400
10Y Growth
17.46%
5Y Growth
13.4%
3Y Growth
23.31%
1Y Growth
N/A

Earnings

14AugExpected
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q1 2024
Q2 2024
857.26
1,010.37
1,163.47
1,316.57
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 023910.KQ. It's not an investment recommendation.
Alphabet
78395
GOOGL
Apple
68177
AAPL
Microsoft
63621
MSFT
Amazon
59331
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Celltrion Pharm
068760.KQ
Mkt Cap2.7T
Celltrion Pharm Inc. competes in the pharmaceutical manufacturing sector in South Korea, offering similar products and competing for the same healthcare market share.
Ildong Pharm
249420.KQ
Mkt Cap0
Chong Kun Dang Pharmaceutical Corp. is a direct competitor in the South Korean pharmaceutical market, producing drugs that rival those of Dai Han Pharmaceutical.

About

Daihan Pharmaceutical Co.,Ltd. engages in the manufacture and sale of therapeutic drugs in South Korea. The company offers various drugs, such as prescription, OTC, and quasi drugs, as well as offers various infusion related solutions. Daihan Pharmaceutical Co.,Ltd. was founded in 1945 and is headquartered in Seoul, South Korea.
Show more...
CEO
Sungyoung Lee
Country
KR
ISIN
KR7023910003

Listings

KQ
KR
023910.KQ